Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of preventing T cell-mediated responses by the use of the major histocompatibility complex class II analog protein (map protein) from Staphylococcus aureus

Method of preventing T cell-mediated responses by the use of the major histocompatibility complex class II analog protein (map protein) from Staphylococcus aureus

US Patent 7153515 · Granted Dec 26, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunoglobulins directed to bacterial, viral and endogenous polypetides2024
Prokaryotic collagen therapeutics for postoperative adhesions2024
Methods and compositions for adaptive immune modulation2023
Sustainable manufacture of foods and cosmetics by computer enabled discovery and2023
Designer collagens and use thereof2023
Targeting of ligand binding sites in ClfA2022
System for identifying and developing individual naturally-occurring proteins as2022
Compositions and use of a fibrinogen binding motif present in EFB and COA for th2022
Crystal structure of Staphylococcus aureus clumping factor A in complex with fib2021
Liquid immersion microscope objective assembly and related systems and methods2021
Specific binding sites in collagen for integrins and use thereof2019
Gene expression profile algorithm and test for likelihood of recurrence of color2019